Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fix Price bought an eight-story business center

1/12/24 FIXP

TZA reported for 9 months of 2023 by RAS

1/12/24 TUZA

Investors invested more than ₽1.1 trillion in securities on the Moscow Exchange in 2023

1/12/24 MOEX

Henderson's revenue for 2023 grew 35 percent

1/12/24 HNFG

SFI began directly owning its quasi-treasury shares

1/11/24 SFIN

Sollers increased sales by 17% in 2023

1/11/24 SVAV

Severstal may resume dividend payments

1/11/24 CHMF

More than half of TGC-2 shares were transferred to Rosimushchestvo

1/11/24 TGKB

Phosagro increased the capacity of the Balakovo branch of Apatit

1/11/24 PHOR

Cost of CHPP-2 modernization almost tripled in 5 years

1/11/24 HYDR